These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15350518)

  • 1. Antibody zymography: a novel adaptation of zymography to determine the protease-neutralising potential of specific antibodies and snake antivenoms.
    Hasson SS; Theakston RD; Harrison RA
    J Immunol Methods; 2004 Sep; 292(1-2):131-9. PubMed ID: 15350518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on pharmacological effects of Russell's viper and Saw-scaled viper venom and its neutralization by chicken egg yolk antibodies.
    Meenatchisundaram S; Parameswari G; Michael A; Ramalingam S
    Int Immunopharmacol; 2008 Aug; 8(8):1067-73. PubMed ID: 18550009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming.
    Harrison RA
    Vaccine; 2004 Apr; 22(13-14):1648-55. PubMed ID: 15068847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Echis carinatus venom antibodies from chicken egg yolk: isolation, purification and neutralization efficacy.
    Paul K; Manjula J; Deepa EP; Selvanayagam ZE; Ganesh KA; Subba Rao PV
    Toxicon; 2007 Dec; 50(7):893-900. PubMed ID: 17681579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivenom cross neutralisation in a suspected Asian pit viper envenoming causing severe coagulopathy.
    Isbister GK; Maduwage K; Page CB
    Toxicon; 2014 Nov; 90():286-90. PubMed ID: 25178876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of IgY(DeltaFc) antibody based neuro toxin antivenoms and the study on their neutralization efficacies.
    Chiou VY
    Clin Toxicol (Phila); 2008 Jul; 46(6):539-44. PubMed ID: 18584367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization potency of Russell's viper venom toxoid antivenom, as compared with standard antivenom.
    Mandal M; Hati RN; Hati AK
    Indian J Med Res; 1992 Aug; 96():219-22. PubMed ID: 1428059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an ELISA assay to determine neutralising capacity of horse serum following immunisation with Daboia siamensis venom in Myanmar.
    Khaing EM; Hurtado PR; Hurtado E; Zaw A; White J; Warrell DA; Alfred S; Mahmood MA; Peh CA
    Toxicon; 2018 Sep; 151():163-168. PubMed ID: 30017790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of a novel antivenom against Atractaspis and Walterinnesia venoms.
    Ismail M; Al-Ahaidib MS; Abdoon N; Abd-Elsalam MA
    Toxicon; 2007 Jan; 49(1):8-18. PubMed ID: 17097125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross neutralization of the lethal activities of Myanmar and Thai Russell's viper venoms by Thai and Myanmar antivenoms.
    Win-Aung ; Pakmanee N; Khow O; Nambut C; Sitprija V
    J Nat Toxins; 2001 Nov; 10(4):335-42. PubMed ID: 11695822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercial monovalent antivenoms in Australia are polyvalent.
    O'Leary MA; Isbister GK
    Toxicon; 2009 Aug; 54(2):192-5. PubMed ID: 19375442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of the pharmacological effects of Cobra and Krait venoms by chicken egg yolk antibodies.
    Meenatchisundaram S; Parameswari G; Michael A; Ramalingam S
    Toxicon; 2008 Aug; 52(2):221-7. PubMed ID: 18590753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and preclinical assessment of camelid immunoglobulins against Echis sochureki venom from desert of Rajasthan, India.
    Tanwar PD; Ghorui SK; Kochar SK; Singh R; Patil NV
    Toxicon; 2017 Aug; 134():1-5. PubMed ID: 28528176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
    Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
    Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of whole IgG equine antivenom: comparison between normal and envenomed rabbits.
    Quesada L; Sevcik C; Lomonte B; Rojas E; Gutiérrez JM
    Toxicon; 2006 Sep; 48(3):255-63. PubMed ID: 16863656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of antibodies specific for toxic sPLA2s and haemorrhagins in neutralizing potential of antisera raised against Vipera ammodytes ammodytes venom.
    Halassy B; Habjanec L; Brgles M; Balija ML; Leonardi A; Kovacic L; Prijatelj P; Tomasić J; Krizaj I
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Aug; 148(2):178-83. PubMed ID: 18571473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of passive haemagglutination (PHA) and haemagglutination inhibition (HAI) technique for potency estimation of Cobra Antisnake Venom Serum (ASVS).
    Pradhan S; Kumar S; Singh D; Sood RC; Sehgal R
    Biologicals; 2007 Jun; 35(3):155-60. PubMed ID: 17088076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of camelid IgG for antivenom development: Immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatment.
    Cook DA; Samarasekara CL; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(4):596-603. PubMed ID: 20547172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of a monoclonal antibody capable of neutralising the haemorrhagic activity of West African Echis carinatus (carpet viper) venom.
    Iddon D; Hommel M; Theakston RD
    Toxicon; 1988; 26(2):167-79. PubMed ID: 3284002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of process to produce polyvalent IgY antibodies anti-African snake venom.
    de Almeida CM; da Silva CL; Couto HP; Escocard Rde C; da Rocha DG; Sentinelli Lde P; Kipnis TL; da Silva WD
    Toxicon; 2008 Aug; 52(2):293-301. PubMed ID: 18621073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.